MSLN and neoplasm: In addition, we evaluated the expression of MSLN in four specific areas (i.e., submucosa, subserosa, central area, and superficial tumor area) by immunohistochemical staining and found that MSLN expression exhibits little heterogeneity and correlates with poorer prognosis regardless of the area [14].